News and views on the clinical trials industry
May 14
Survey: Confusing rules governing pediatric trials add to bigger challenge of finding enough participants
Researchers: Current ethics don't cover phase IV, as trials produce biased marketing detached from science
To read the full articles for this issue of CWWeekly, please click here for subscription information.
Already a digital subscriber? Access this issue now.
May
Newer sites most optimistic about the future
Investigative sites of all sizes, from part-time physician-run sites to large dedicated research centers, report a rebound in operating conditions, according to a new CenterWatch analysis, yet sites from each subgroup indicate they have concerns…
Risk-based monitoring slow to catch on with industry
It's estimated that the cost of physically sending monitors to all investigative sites at regular intervals, a model the industry itself developed and has adhered to for about a decade, eats up one-third to one-half of…
Eye On Millennium
Millennium, The Takeda Oncology Company, discovers and develops novel treatments applying world-class recombinant technology to a wide variety of oncology disease targets…
To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.
Already a digital subscriber? Access this issue now.
